The Mosaic Company
MOS
$19.82
-6.86%
The Mosaic Company is a global leader in the production and marketing of concentrated phosphate and potash crop nutrients, operating within the Agricultural Inputs industry. As one of the world's largest integrated producers of phosphate and potash, the company's distinct competitive position is anchored in its ownership of low-cost rock mines in the US and Canada, and a significant distribution network in Brazil through its Mosaic Fertilizantes business. The current investor narrative is dominated by volatile fertilizer prices, geopolitical supply chain disruptions, and the cyclical downturn from peak earnings, with recent news highlighting potential margin opportunities from the closure of the Strait of Hormuz which has stranded a significant portion of global supply, directly benefiting North American producers like Mosaic.…
MOS
The Mosaic Company
$19.82
MOS 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Mosaic Company's 12-month outlook, with a consensus price target around $25.77 and implied upside of +30.0% versus the current price.
Average Target
$25.77
13 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
13
covering this stock
Price Range
$16 - $26
Analyst target range
A cohort of 13 analysts provides coverage, indicating solid institutional interest. The consensus sentiment is neutral to cautious, as evidenced by recent rating actions including downgrades from 'Buy' to 'Neutral' (B of A Securities) and 'Overweight' to 'Equal Weight' (Barclays) in March 2026. The average revenue estimate for the coming period is $11.6 billion, with a wide range from $10.45 billion to $12.79 billion, reflecting uncertainty in fertilizer price forecasts. The average EPS estimate is $2.23, bracketed by a low of $1.94 and a high of $2.53. The wide target price range implied by these estimates signals high uncertainty around the company's earnings power in the volatile commodity environment; the high-end scenario likely assumes a recovery in fertilizer prices and margin expansion, while the low-end may price in prolonged weak demand and compressed spreads.
Bulls vs Bears: MOS Investment Factors
The bull and bear cases are sharply divided on whether Mosaic represents a deep-value opportunity or a value trap in a prolonged cyclical downturn. The bull case is anchored in extreme valuation discounts (P/B of 0.63x), a strong balance sheet, and a potential geopolitical supply shock catalyst. The bear case is driven by severe fundamental deterioration, including negative free cash flow, margin compression, and persistent negative price momentum. Currently, the bearish evidence appears stronger, given the concrete data showing revenue declines, cash burn, and a stock in free-fall. The single most important tension in the investment debate is the timing and magnitude of a fertilizer price recovery. If supply disruptions materialize and prices rebound, the stock's deep undervaluation could lead to a powerful rally. If the downturn persists, the negative cash flow and earnings decline could push the stock toward its 52-week low.
Bullish
- Deeply Undervalued vs. Assets: Mosaic trades at a significant discount to its book value, with a Price-to-Book ratio of 0.63x, indicating the market values the company below its stated equity. This is well below historical highs above 2.0x and suggests the stock is pricing in a deep cyclical trough, potentially overlooking the long-term value of its low-cost rock mines.
- Strong Balance Sheet & Low Debt: The company maintains a manageable debt-to-equity ratio of 0.44 and a current ratio of 1.32, indicating a solid financial position with adequate liquidity. This provides resilience to weather the current cyclical downturn without significant balance sheet stress.
- Potential Geopolitical Supply Catalyst: Recent news highlights the closure of the Strait of Hormuz, which has stranded a third of global fertilizer supply. As a North American producer with local inputs, Mosaic stands to benefit from a massive margin opportunity if this disruption persists, providing a potential near-term catalyst.
- Analyst EPS Growth Implied: The forward P/E of 12.5x is lower than the trailing P/E of 14.1x, based on an average EPS estimate of $2.23. This forward discount suggests the market expects an earnings recovery from the current depressed levels, with analyst estimates implying a significant year-over-year improvement.
Bearish
- Severe Cyclical Downturn & Price Pressure: The company is in a pronounced cyclical downturn, with revenue declining 7.6% YoY in Q4 2025 and net margin compressing sharply from 11.9% in Q3 to 6.2% in Q4. This reflects significant pricing pressure on phosphate and potash, with no clear near-term bottom in sight.
- Negative Free Cash Flow & Cash Burn: Trailing twelve-month free cash flow is deeply negative at -$535 million, and the latest quarterly operating cash flow was -$56 million. This cash burn raises concerns about the sustainability of capital returns and could pressure the dividend if fertilizer prices do not recover.
- Persistent Negative Momentum & Underperformance: The stock is down 37.8% over the past year, underperforming the S&P 500 by nearly 65 percentage points, and is currently trading just 13% above its 52-week low of $20.89. This severe technical breakdown reflects overwhelming investor pessimism and a lack of positive catalysts.
- Analyst Downgrades & Neutral Sentiment: Recent analyst actions include downgrades from 'Buy' to 'Neutral' and 'Overweight' to 'Equal Weight' in March 2026. This shift to a cautious consensus, coupled with a wide target price range, reflects high uncertainty and a lack of conviction in a near-term recovery.
MOS Technical Analysis
The stock is in a pronounced downtrend, with a 1-year price change of -37.8%, severely underperforming the S&P 500's 27.04% gain by nearly 65 percentage points. Currently trading at $22.90, the price is near the bottom of its 52-week range (low: $20.89, high: $38.23), positioning it at approximately 13% above the 52-week low, which suggests the stock is deeply oversold and may represent a value opportunity, though it also signals significant negative momentum and investor pessimism. Recent momentum remains weak, with the stock down 1.5% over the past month and 13.0% over the past three months, continuing the longer-term bearish trend without signs of a meaningful reversal; the 3-month relative strength of -25.6 against the S&P 500 confirms this persistent underperformance. Key technical support is the 52-week low of $20.89, with a breach potentially signaling further downside, while resistance is at the 52-week high of $38.23. The stock's beta of 0.797 indicates it is about 20% less volatile than the broader market, which is atypical for a cyclical commodity stock and may reflect its large-cap status and heavy institutional ownership, but this lower beta has not protected it from a severe drawdown of -43.4%.
Beta
0.81
0.81x market volatility
Max Drawdown
-47.6%
Largest decline past year
52-Week Range
$20-$38
Price range past year
Annual Return
-41.8%
Cumulative gain past year
| Period | MOS Return | S&P 500 |
|---|---|---|
| 1m | -9.0% | -1.9% |
| 3m | -36.8% | +8.9% |
| 6m | -24.4% | +6.4% |
| 1y | -41.8% | +20.3% |
| ytd | -20.8% | +6.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MOS Fundamental Analysis
Revenue and profitability are under significant pressure, reflecting the cyclical downturn in fertilizer markets. Q4 2025 revenue was $2.60 billion, representing a year-over-year decline of 7.6%, and this follows a sequential decline from Q3's $3.45 billion, indicating decelerating top-line momentum. Segment data shows the Phosphates segment contributed $1.01 billion and Potash $681 million in the latest quarter, with the Mosaic Fertilizantes distribution business being the largest at $1.15 billion, highlighting its importance but also exposure to Brazilian market dynamics. The company remains profitable but margins have compressed sharply; Q4 2025 net income was $162 million, yielding a net margin of 6.2%, a significant drop from the 11.9% net margin in Q3 2025, while the gross margin of 14.2% in Q4 is down from 16.0% in the prior quarter, indicating pricing pressure on key products. The balance sheet and cash flow position present a mixed picture: the debt-to-equity ratio is a manageable 0.44, and the current ratio of 1.32 indicates adequate short-term liquidity. However, trailing twelve-month free cash flow is deeply negative at -$535 million, and the latest quarterly operating cash flow was -$56 million, suggesting the company is consuming cash to fund operations and capital expenditures, which could pressure the dividend (payout ratio of 52%) if sustained.
Quarterly Revenue
$2.6B
2025-12
Revenue YoY Growth
-0.07%
YoY Comparison
Gross Margin
+0.14%
Latest Quarter
Free Cash Flow
$-534600000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MOS Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E is 14.1x, while the forward P/E is 12.5x, based on estimated EPS of $2.23; the lower forward multiple suggests the market expects earnings recovery, though the modest discount implies tempered optimism. Compared to sector averages, Mosaic trades at a significant discount: its trailing P/E of 14.1x and Price-to-Sales (P/S) of 0.63x are well below typical commodity chemical multiples, and its Price-to-Book of 0.63x indicates the market values the company below its stated equity, often a sign of perceived asset impairment or low return prospects. Historically, the stock's own valuation has compressed dramatically; the current P/B of 0.63 is near the bottom of its multi-year range and compares to highs above 2.0x in early 2022, while the P/S of 0.63 is also at depressed levels versus historical norms above 3.0x, signaling the market is pricing in a deep cyclical trough and potentially overlooking the long-term asset value.
PE
14.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -702x~58x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on cash flow sustainability and margin volatility. The company is burning cash, with TTM FCF at -$535M and Q4 operating cash flow negative at -$56M. This raises the risk of a dividend cut from its current 3.67% yield if the payout ratio of 52% becomes unsustainable. Furthermore, net margins have compressed sharply from 11.9% in Q3 to 6.2% in Q4, indicating high operational leverage to volatile fertilizer prices. Revenue concentration in the cyclical Phosphates and Potash segments, with the Brazilian distribution business adding geopolitical and currency risk, creates earnings instability that the market is punishing.
Market & Competitive Risks are dominated by commodity cycle exposure and valuation compression. Mosaic's stock has a beta of 0.80, but this has not protected it from a -43.4% drawdown, highlighting its sensitivity to fertilizer prices rather than the broader market. Trading at a P/E of 14.1x and P/S of 0.63x, it is at a discount to sector peers, but this discount could persist or widen if the cycle trough is deeper than expected. The recent analyst downgrades to Neutral/Equal Weight reflect this fear of prolonged weakness. Competitive pressures from other global producers and potential shifts in agricultural demand pose constant threats to pricing power.
Worst-Case Scenario involves a prolonged global fertilizer glut combined with a recession in key agricultural markets like Brazil, leading to a multi-year downturn. In this scenario, earnings could fall toward the analyst low EPS estimate of $1.94, and the stock's valuation could re-test its tangible book value support. The realistic downside from the current price of $22.90 is a decline to the 52-week low of $20.89, representing a -9% loss, or potentially further to the $18-$19 range if sentiment sours further, implying a total downside risk of -15% to -20%. A breach of the 52-week low could trigger accelerated technical selling.